The Emerging Leader Award program aims to empower early career investigators to take on innovative, risky projects that have significant potential to improve outcomes for cancer patients.
NewsJan | 6 | 2020
Mario Suva, MD, PhD Named One of Six Recipients of The Mark Foundation 2020 Emerging Leader Awards
The Mark Foundation Announces 2020 Emerging Leader Awards | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research (MFCR) has awarded six grants to promising early career scientists for projects aimed at addressing unmet needs in cancer research. Mario Suvà, MD, PhD, of Massachusetts General Hospital was one of the six recipeints for his project “Targeting Cellular States and Plasticity in Glioblastoma”.
The Mark Foundation for Cancer Research (MFCR) has awarded six grants to promising early career scientists for projects aimed at addressing unmet needs in cancer research. Mario Suvà, MD, PhD, of Massachusetts General Hospital was one of the six recipeints for his project “Targeting Cellular States and Plasticity in Glioblastoma”.
Related News and Articles
- News
- Aug | 22 | 2022
When Recovery Goes Awry
New findings reveal how recovery progresses following inflammation triggered by injury or illness
- News
- Dec | 10 | 2020
Mass General History Award: Celebrating “Keen Minds”
David N. Louis, MD, and Robert H. Young, MD, have received the 2020 Patricia R. Austen, RN, MGH History Award. The award honors individuals or groups who have worked to promote or preserve Mass General history.
- News
- Aug | 25 | 2020
Phylogenetic analysis of SARS-CoV-2 in the Boston area highlights the role of recurrent importation and superspreading events.
SARS-CoV-2 has caused a severe, ongoing outbreak of COVID-19 in Massachusetts. To investigate the introduction, spread, and epidemiology of COVID-19 in the Boston area, we sequenced and analyzed 772 complete SARS-CoV-2 genomes from the region.
1of
6